CXS-2101

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCXS-2101
Drug Alias Namechemosensitizers (ChemGenex)NF-kappaB inhibitors (ChemGenex)1-SP-4-841-SP-6-95CSX-2101 +[7] 
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemgenex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemgenex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A